Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of ARNTL mRNA | decreases expression | 19933214
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene results in increased expression of ARNTL mRNA | increases expression | 20406850
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of ARNTL mRNA | affects expression | 17562736
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of ARNTL mRNA | affects expression | 16483693
|
D019324 |
beta-Naphthoflavone |
beta-Naphthoflavone inhibits the reaction [CLOCK protein binds to ARNTL protein] | affects binding|decreases reaction | 20106950
|
D019324 |
beta-Naphthoflavone |
beta-Naphthoflavone promotes the reaction [AHR protein binds to ARNTL protein] | affects binding|increases reaction | 20106950
|
D019324 |
beta-Naphthoflavone |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of ARNTL mRNA | affects cotreatment|decreases expression | 18164116
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ARNTL mRNA | decreases expression | 19150397
|
D004041 |
Dietary Fats |
Dietary Fats results in decreased expression of ARNTL mRNA | decreases expression | 18042831
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of ARNTL mRNA | affects cotreatment|decreases expression | 18164116
|
D005419 |
Flavonoids |
Flavonoids results in decreased expression of ARNTL mRNA | decreases expression | 18035473
|
C041786 |
palm oil |
palm oil results in decreased expression of ARNTL mRNA | decreases expression | 18042831
|
D010634 |
Phenobarbital |
Phenobarbital results in decreased expression of ARNTL mRNA | decreases expression | 19270015
|
D010634 |
Phenobarbital |
Phenobarbital results in increased expression of ARNTL mRNA | increases expression | 19270015
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of ARNTL mRNA | decreases expression | 17426115
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of ARNTL mRNA | increases expression | 18445702
|
C002979 |
selenomethylselenocysteine |
selenomethylselenocysteine results in decreased expression of ARNTL mRNA | decreases expression | 19122877
|
C009250 |
sevoflurane |
sevoflurane affects the expression of ARNTL mRNA | affects expression | 15967596
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of ARNTL mRNA | increases expression | 18812580
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of ARNTL mRNA | decreases expression | 18295293 19933214
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of ARNTL mRNA | increases expression | 18487412
|
D014212 |
Tretinoin |
RARA protein inhibits the reaction [Tretinoin results in increased activity of [CLOCK protein binds to ARNTL protein]] | affects binding|decreases reaction|increases activity | 17069763
|
D014212 |
Tretinoin |
Tretinoin results in increased activity of [CLOCK protein binds to ARNTL protein] | affects binding|increases activity | 17069763
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of ARNTL mRNA | increases expression | 9704006
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
8.27 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.27 | 15322242 14514962 11752688 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.55 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.10 | 18653653 |
MESH:D000236 |
Adenoma |
|
beta-Naphthoflavone |
6.84 | 19389873 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
6.84 | 6695378 10737359 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
24.82 | 16434500 19052882 17162532 19061943 18056438 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
24.82 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
24.82 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
24.82 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.70 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.90 | 17306315 16712894 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.60 | 15955085 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.93 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.84 | 10982225 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
3.87 | 15238619 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.06 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.26 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.34 | 16456186 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.42 | 18445737 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.39 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
15.17 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
15.17 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
15.17 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.79 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.75 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
2.35 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
2.35 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
selenomethylselenocysteine |
2.35 | 18855134 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.35 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.35 | 16166294 16873071 16443354 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.58 | 16813970 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.78 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.16 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
11.36 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
11.36 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
11.36 | 10672840 18691550 17173139 16830150 16288022 18788625 20514400 17162532 20214788 19107877 17138121 18978308 19171122 20432363 16935385 18056438 17978847 19383236 19539802 16698587 17055752 16681979 19919837 18494052 18506893 16502159 16569478 16878318 19208518 20727157 19701751 16328049 11831363 16540662 10737359 19822196 19335982 20084675 3581430 20512989 21159647 20007298 19418558 20935162 16779866 20524982 20101231 16807293 18393292 18785209 17761372 17428255 19394651 18971187 19519916 3084413 18210153 19052882 18665156 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
11.36 | 17173139 20935162 6705139 1701930 20007298 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
11.36 | 16507464 15276417 17306315 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
11.36 | 1917145 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
4.67 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
4.67 | 16051514 16096774 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.35 | 18850075 18670907 16120746 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
7.18 | 10977129 |
MESH:D002386 |
Cataract |
|
Tretinoin |
7.18 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
15.91 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
15.91 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
15.91 | 2727394 7505956 17174075 21159647 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
15.91 | 20056578 19524636 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
4.24 | 4080065 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.58 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
9.26 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
9.26 | 16835633 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
2.81 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.16 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.74 | 15340226 8697196 12621046 15668235 16354765 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.74 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.69 | 17035595 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.04 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.44 | 15322242 20055451 10048152 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
2.44 | 16925845 8800419 17551590 9211117 10589399 14991402 9142499 9664655 9224671 9125849 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.00 | 18551238 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.41 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
4.20 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.20 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
8.90 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
8.90 | 19370779 14550746 16227642 11287661 17522070 10915739 17562736 14725611 16081117 12705907 16781746 19739265 16177239 11529661 11421492 17906064 16109766 12540782 19085960 11743745 15968718 19420014 11834606 11739529 12958197 12153990 11461765 10663392 14986274 12594235 12392966 19164858 10774834 16393943 19416960 15619225 16485898 2444490 18071297 19923254 18713872 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
8.90 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
8.90 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.10 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.74 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.44 | 18367378 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
3.99 | 1851702 |
MESH:D004487 |
Edema |
|
pirinixic acid |
6.48 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.48 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
11.95 | 16714409 15322242 18230668 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
11.95 | 18230668 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
3.09 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.00 | 9294722 10568697 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
4.09 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
3.87 | 11558140 3922381 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
2.88 | 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.52 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
4.24 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
4.01 | 3659116 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.12 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.07 | 20426865 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.78 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.78 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
13.00 | 19551842 18296743 19004024 17967931 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
13.00 | 20387270 21071580 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
13.00 | 20131406 19236843 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.44 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
14.70 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
14.70 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
14.70 | 17994277 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.68 | 16983495 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.67 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
2.99 | 17312396 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.59 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.17 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.16 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.50 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
6.50 | 9664655 14991402 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.52 | 20558911 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.32 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
14.31 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
14.31 | 18467677 16221962 19176532 19772884 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
14.31 | 12621046 16120746 15340226 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.13 | 12676792 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.05 | 16354765 18606429 16959395 15340226 8697196 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
7.57 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
7.57 | 16870215 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.57 | 21332399 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.55 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.16 | 20558911 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.60 | 21332399 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.90 | 18850075 18670907 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
2.97 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
11.87 | 20412841 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
11.87 | 18785209 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
11.87 | 17296493 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
11.87 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
7.20 | 11836018 18457598 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
7.20 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.75 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.87 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
9.87 | 17551590 15992940 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
5.92 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
5.92 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
2.96 | 16705839 |
MESH:D007859 |
Learning Disorders |
|
sevoflurane |
4.76 | 19212262 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.76 | 17143497 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
marker/mechanism |
|
| 16999817 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.68 | 16482212 16932348 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.07 | 16294345 19850784 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.14 | 16823087 17506722 9834237 12679006 17217047 17649720 19642359 16788101 17339181 19075265 16140955 16331271 17361223 19029980 17294898 17301526 19035177 15748426 17107899 16766008 17712046 19225113 16891316 17368321 16935935 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.29 | 9224671 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
10.96 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
10.96 | 18522880 18407596 18665156 20032147 19638242 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
10.96 | 21047994 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.38 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.38 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
3.38 | 16248980 18397230 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
6.45 | 11587558 19014921 16611625 12969438 12587719 19784758 16610002 19460945 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
6.45 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
6.45 | 19363144 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.22 | 16871587 17185352 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
21.81 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
beta-Naphthoflavone |
21.81 | 21295105 19389873 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
21.81 | 2862719 20137499 20118626 12771043 21071580 19254457 15885732 20101389 19294768 19690152 19642983 12112319 20583210 18648771 18978307 18977376 19255062 19426721 19996281 21278145 21167192 15175105 20501860 19499222 19073162 19638242 21047994 9163691 20434301 19551842 19812893 19256749 20492335 19833225 19090486 19427195 16942905 18754104 10737359 20452335 19850985 2422723 20405173 18644402 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
21.81 | 19812893 19482888 8742319 19073162 21047994 15975961 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
21.81 | 16377806 20007298 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
21.81 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
21.81 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
18.52 | 2876784 6135515 2876786 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
beta-Naphthoflavone |
18.52 | 18164116 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
18.52 | 16267830 3124819 9362446 18093689 21159647 18544905 19519916 18775883 19539802 18079962 19009564 17854601 16842330 18253720 17174075 17942915 19004024 18164116 18308698 2563599 18282651 19126423 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
18.52 | 18308698 6150874 2563599 1399818 17172636 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
18.52 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.16 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
3.38 | 21163286 20970405 6695378 20512841 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
3.38 | 19931552 15276417 16712894 17077188 17306315 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.38 | 19555203 11884234 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
selenomethylselenocysteine |
4.20 | 15318939 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.78 | 17453147 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
3.33 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
3.33 | 16752155 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.55 | 19513568 |
MESH:D008569 |
Memory Disorders |
|
sevoflurane |
4.73 | 19212262 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.41 | 16940565 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.49 | 16239165 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.07 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.13 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.00 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.93 | 16411023 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.47 | 17484760 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
3.85 | 18551238 7678174 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.56 | 9029167 3581430 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
8.18 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
8.18 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
8.18 | 16946489 16594593 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.65 | 20056578 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.46 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
9.46 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
7.26 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
7.26 | 9142499 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
8.12 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
8.12 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.12 | 20387270 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
4.42 | 16723640 17217161 20132043 20518802 18457598 21332399 19632207 18674790 11836018 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
4.42 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.41 | 16049721 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
4.36 | 17016548 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
4.86 | 15276417 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
4.86 | 16936753 |
MESH:D010146 |
Pain |
|
Acetaminophen |
6.53 | 16870215 |
MESH:D010146 |
Pain |
|
Tretinoin |
6.53 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
8.57 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
8.57 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
8.57 | 15976015 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.25 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.54 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
9.03 | 2563599 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
9.03 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.18 | 11399792 11118676 11222880 11896295 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.31 | 16039940 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.59 | 16636307 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
4.50 | 12752131 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.78 | 16723453 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.38 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.82 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.08 | 16283617 16116481 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
5.88 | 18551238 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
5.88 | 3137016 4039156 11442880 16876388 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.81 | 6407741 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
9.37 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
9.37 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
9.37 | 16467112 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.78 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
2.41 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
2.41 | 17261132 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.90 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
11.88 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
11.88 | 1399818 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
11.88 | 16026305 17045167 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.77 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.21 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
5.07 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
5.07 | 11723127 16452187 16712894 17306315 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.31 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.96 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
9.35 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
9.35 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.61 | 16752155 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.42 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.59 | 12125929 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.04 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.25 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.72 | 16723640 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.95 | 16287080 |